The mission of the Tufts Health Care Institute Program on Opioid Risk Management is to address challenges in the development and utilization of opioid analgesics, by engaging a multidisciplinary group of stakeholders focused on optimizing the benefits of opioid for pain management, and minimizing their risks, including abuse and diversion.

October 27 - 28, 2005
Opioid Abuse Resistance

Executive Summary

October 2005

Agenda

The Phenomenology of Prescription Opioid Abuse:
What Types of Abuse Do Products Need to Resist?
Sidney H. Schnoll, MD, PhD Presentation >>

Extractability Discussion
Nathaniel Katz, MD, MS Presentation >>

The Quest for Non-Abusable Opioid Analgesics
Charles Grudzinskas, PhD Presentation >>

FDA Concerns Regarding the Development of Abuse-Resistant Products
Bob Rappaport, MD Presentation >>

Industry Incentives, Industry Risks
Debra Travers, MT (ASCP) Presentation >>

Labeling Considerations
William Pierce, PharmD Presentation >>

Regulation of Prescription Drug Promotion
Elaine J. Hu, RPh Presentation >>

Benchtop Evaluations of Tampering with Pharmaceutical Dosage Forms
Philip Goliber, PhD Presentation >>

Substance Abuse Issues in Pain Management
Steven D. Passik, PhD Presentation >>

Can Epidemiologic Studies Be Used to Measure Abuse Resistance?
Howard Chilcoat, ScD Presentation >>